Pharmaceutical Executive
Merck bolsters vaccine making division with the addition of 400 new employees to fill its new manufacturing plant.
Pharmaceutical Executive-06-25-2008
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
How Does FDA's Single Trial Decision Change The Risk Calculus for Sponsors
3
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
4
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
5